Opus Genetics, Inc. · NASDAQ:IRD
Nantahala Capital Management, LLC reported a 6.51% stake in Opus Genetics, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Nantahala Capital Management, LLC reported a 6.51% stake in Opus Genetics, Inc., 4,839,225 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 6.51%
- Shares
- 4,839,225
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Nantahala Capital Management, LLC | 6.51% | 4,839,225 |
| Wilmot B. Harkey | 6.51% | 4,839,225 |
| Daniel Mack | 6.51% | 4,839,225 |
Source
Related
- Opus Genetics, Inc.
- Nantahala Capital Management, LLC
- Opus Genetics, Inc. shareholders
- Schedule 13G/A · Nantahala Capital Management, LLC · Feb 13, 2026
- Schedule 13G/A · Nantahala Capital Management, LLC · Aug 14, 2025
- Schedule 13G · Nantahala Capital Management, LLC · May 15, 2025
- Form 4 · Foundation Fighting Blindness Retinal Degeneration Fund · Oct 2, 2026
- Form 4 · Magrath George · Sep 11, 2026
- Form 4 · Gallagher Cam · Sep 8, 2026
- Form 4 · Gagnon Robert E. · Sep 8, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026